Editorial: aminosalicylates in Crohn’s disease-prevalence, risks, costs and time to reassess? Authors’ reply.

Editorial: aminosalicylates in Crohn’s disease-prevalence, risks, costs and time to reassess? Authors’ reply.

Aliment Pharmacol Ther. 2018 Aug;48(4):489

Authors: Jairath V, Ma C, Feagan B

PMID: 30284736 [PubMed – in process]

PubMed Link: https://www.ncbi.nlm.nih.gov/pubmed/30284736?dopt=Abstract